Works matching AU Martelli, Maurizio
Results: 107
Red Blood Cell Distribution Width May Predict Drug-Induced Anemia and Prognosis in Patients Affected by Primary/Secondary Myelofibrosis Treated with Ruxolitinib.
- Published in:
- Oncology & Therapy, 2025, v. 13, n. 1, p. 165, doi. 10.1007/s40487-024-00322-2
- By:
- Publication type:
- Article
PET-Based Risk Stratification in Primary Mediastinal B-Cell Lymphoma: A Comparative Analysis of Different Segmentation Methods in the IELSG37 Trial Patient Cohort.
- Published in:
- Journal of Nuclear Medicine, 2025, v. 66, n. 2, p. 209, doi. 10.2967/jnumed.124.268874
- By:
- Publication type:
- Article
Single centre experience on Acquired Haemophilia A patients: Diagnosis, clinical management and analysis of factors predictive of response and outcome.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. e667, doi. 10.1111/hae.14395
- By:
- Publication type:
- Article
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 9, p. e286, doi. 10.1016/j.clml.2023.06.001
- By:
- Publication type:
- Article
Management of Chronic Myeloid Leukemia Patients in Later Lines: The Role of Ponatinib and New Compounds.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 6, p. 420, doi. 10.1016/j.clml.2023.03.004
- By:
- Publication type:
- Article
Baseline Total Metabolic Tumor Volume is Prognostic for Refractoriness to Immunochemotherapy in DLBCL: Results From GOYA.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e804, doi. 10.1016/j.clml.2022.04.010
- By:
- Publication type:
- Article
BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single center prospective evaluation and desensitization strategies employed.
- Published in:
- Blood Transfusion (17232007), 2024, v. 22, n. 5, p. 157, doi. 10.2450/BloodTransfus.464
- By:
- Publication type:
- Article
Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single Center prospective evaluation and desensitization strategies employed.
- Published in:
- Blood Transfusion (17232007), 2024, v. 22, n. 2, p. 157, doi. 10.2450/BloodTransfus.464
- By:
- Publication type:
- Article
COVID-19 in Patients with Hematologic Disorders Undergoing Therapy: Perspective of a Large Referral Hematology Center in Rome.
- Published in:
- Acta Haematologica, 2020, v. 143, n. 6, p. 574, doi. 10.1159/000510769
- By:
- Publication type:
- Article
Anaplastic large cell lymphoma (CD30+/Ki-1+): results of a prospective clinico-pathological study of 69 cases.
- Published in:
- British Journal of Haematology, 1994, v. 86, n. 3, p. 513, doi. 10.1111/j.1365-2141.1994.tb04781.x
- By:
- Publication type:
- Article
Different prognosis according to treatment in patients with acute promyelocytic leukemia: How the outcome changed over time.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 12, p. 5377, doi. 10.1007/s00277-024-06014-1
- By:
- Publication type:
- Article
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 12, p. 3457, doi. 10.1007/s00277-023-05412-1
- By:
- Publication type:
- Article
Myelodysplastic clones arising post chimeric antigen receptor t cell therapy (car-t) procedure: a casuality or a new entity?
- Published in:
- Annals of Hematology, 2023, v. 102, n. 10, p. 2963, doi. 10.1007/s00277-023-05329-9
- By:
- Publication type:
- Article
Impact of gemtuzumab ozogamicin consolidation on hematopoietic stem cells (HSCs) mobilization in AML: analysis of 20 patients.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 769, doi. 10.1007/s00277-023-05129-1
- By:
- Publication type:
- Article
Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Switch from branded to generic imatinib: impact on molecular responses and safety in chronic-phase chronic myeloid leukemia patients.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 12, p. 2773, doi. 10.1007/s00277-020-04096-1
- By:
- Publication type:
- Article
Predictive factors for response and survival in elderly acute myeloid leukemia patients treated with hypomethylating agents: a real-life experience.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 10, p. 2405, doi. 10.1007/s00277-020-04217-w
- By:
- Publication type:
- Article
Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 1, p. 273, doi. 10.3390/jcm13010273
- By:
- Publication type:
- Article
Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 11, p. 3777, doi. 10.3390/jcm12113777
- By:
- Publication type:
- Article
Lymphadenopathies before and during the Pandemic COVID-19: Increasing Incidence of Metastases from Solid Tumors.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 23, p. 6979, doi. 10.3390/jcm11236979
- By:
- Publication type:
- Article
Baseline PET features to predict prognosis in primary mediastinal B cell lymphoma: a comparative analysis of different methods for measuring baseline metabolic tumour volume.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 6, p. 1334, doi. 10.1007/s00259-019-04286-8
- By:
- Publication type:
- Article
Pharmacotherapeutic advances for chronic myelogenous leukemia: beyond tyrosine kinase inhibitors.
- Published in:
- Expert Opinion on Pharmacotherapy, 2024, v. 25, n. 2, p. 189, doi. 10.1080/14656566.2024.2331778
- By:
- Publication type:
- Article
Prognostic models for primary mediastinal (thymic) B-cell lymphoma derived from 18- FDG PET/ CT quantitative parameters in the International Extranodal Lymphoma Study Group ( IELSG) 26 study.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 4, p. 588, doi. 10.1111/bjh.14728
- By:
- Publication type:
- Article
Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes.
- Published in:
- British Journal of Haematology, 2012, v. 156, n. 5, p. 601, doi. 10.1111/j.1365-2141.2011.08962.x
- By:
- Publication type:
- Article
The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in ‘Western’ patients with intravascular large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 2, p. 253, doi. 10.1111/j.1365-2141.2008.07338.x
- By:
- Publication type:
- Article
Unmet needs in relapsed/refractory mantle cell lymphoma after failure of covalent Bruton's tyrosine kinase inhibitors: An Italian scenario.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3246
- By:
- Publication type:
- Article
Impact of anti‐SARS‐CoV‐2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 343, doi. 10.1002/hon.3113
- By:
- Publication type:
- Article
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study)
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 609, doi. 10.1002/hon.3028
- By:
- Publication type:
- Article
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 518, doi. 10.1002/hon.2983
- By:
- Publication type:
- Article
Use of BTK inhibitors with special focus on ibrutinib in Waldenström macroglobulinemia: An expert panel opinion statement.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 3, p. 332, doi. 10.1002/hon.2982
- By:
- Publication type:
- Article
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 5, p. 698, doi. 10.1002/hon.2792
- By:
- Publication type:
- Article
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Training improves the interobserver agreement of the expert positron emission tomography review panel in primary mediastinal B-cell lymphoma: interim analysis in the ongoing International Extranodal Lymphoma Study Group-37 study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy: Results from a monoinstitutional cohort analysis of long-term survivors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Editorial: HBV and lymphoma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1236816
- By:
- Publication type:
- Article
Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1171031
- By:
- Publication type:
- Article
Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1212638
- By:
- Publication type:
- Article
Case Report: Infectious prophylaxis in hematological malignancies.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1163175
- By:
- Publication type:
- Article
Early Palliative Home Care versus Hospital Care for Patients with Hematologic Malignancies: A Cost-Effectiveness Study.
- Published in:
- Journal of Palliative Medicine, 2021, v. 24, n. 6, p. 887, doi. 10.1089/jpm.2020.0396
- By:
- Publication type:
- Article
Rituximab Combined With MACOP-B or VACOP-B and Radiation Therapy in Primary Mediastinal Large B-Cell Lymphoma: A Retrospective Study.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 5, p. 381, doi. 10.3816/CLM.2009.n.074
- By:
- Publication type:
- Article
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study.
- Published in:
- In Vivo, 2020, v. 34, n. 3, p. 1407, doi. 10.21873/invivo.11921
- By:
- Publication type:
- Article
An effective fixpoint semantics for linear logic programs.
- Published in:
- Theory & Practice of Logic Programming, 2002, v. 2, n. 1, p. 85, doi. 10.1017/S1471068402001254
- By:
- Publication type:
- Article
Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1338417
- By:
- Publication type:
- Article
Primary orbital lymphomas: Clinical findings and treatment in ten cases.
- Published in:
- Orbit, 1991, v. 10, n. 3, p. 141, doi. 10.3109/01676839109087657
- By:
- Publication type:
- Article
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 11, p. 1520, doi. 10.1080/0284186X.2021.1971291
- By:
- Publication type:
- Article
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study.
- Published in:
- Infection & Drug Resistance, 2023, v. 16, p. 695, doi. 10.2147/IDR.S393802
- By:
- Publication type:
- Article
RECOGNIZING NON-FLOUNDERING LOGIC PROGRAMS AND GOALS.
- Published in:
- International Journal of Foundations of Computer Science, 1990, v. 1, n. 2, p. 151, doi. 10.1142/S0129054190000126
- By:
- Publication type:
- Article
Leucocytosis during induction therapy with all‐trans‐retinoic acid and arsenic trioxide in acute promyelocytic leukaemia predicts differentiation syndrome and treatment‐related complications.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 5, p. 1727, doi. 10.1111/bjh.19759
- By:
- Publication type:
- Article